Medical Marketing and Media

RSS | Login | Register

Antidote Articles

A new test to identify Down Syndrome

Marc Siegel, MD February 01, 2012

The Materni T21 test has been found sensitve for discovering Down Syndrome in over 99% of cases

Making a political football out of Plan B

Marc Siegel, MD January 01, 2012

The odds on the risks surrounding Plan B change when a teen is not under a doctor's supervision

Antidote: The future of Crestor and Lipitor

Marc Siegel, MD December 01, 2011

Does Crestor have a selective advantage over Lipitor that would make it worth the price difference?

Antidote: the Prostate Specific Antigen

Marc Siegel, MD November 01, 2011

In two studies, the PSA was found to lower the prostate cancer death rate by more than 30 percent

Antidote: drug shortages

Marc Siegel, MD October 01, 2011

Over 80% of hospitals report that shortages of lifeseaving drugs are delaying patient care

A promising new leukemia treatment

Marc Siegel, MD August 15, 2011

This time, the media is being very positive. News reports about the new treatment for chronic lymphocytic leukemia are ripe with palpable excitement.

Antidote: Chantix

Marc Siegel, MD July 15, 2011

One out of five Americans still smokes, and smoking leads to cancer and heart disease.

Antidote: simvastatin

Marc Siegel, MD June 15, 2011

The problem with a media-megaphoned report about a drug's potential side effect is that it too easily balloons into a fear-driven avoidance of a life-saving group of drugs.

Antidote: Vicodin

Marc Siegel, MD May 13, 2011

A recent survey from IMS Health reveals that Vicodin is the most frequently prescribed painkiller in the US, with 131 million prescriptions written over the past year alone.